DE3750139D1 - Bakterielle antigene, antikörper, impfstoffe und deren herstellung. - Google Patents

Bakterielle antigene, antikörper, impfstoffe und deren herstellung.

Info

Publication number
DE3750139D1
DE3750139D1 DE3750139T DE3750139T DE3750139D1 DE 3750139 D1 DE3750139 D1 DE 3750139D1 DE 3750139 T DE3750139 T DE 3750139T DE 3750139 T DE3750139 T DE 3750139T DE 3750139 D1 DE3750139 D1 DE 3750139D1
Authority
DE
Germany
Prior art keywords
gbs
polysaccharide
vaccine
antibodies
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3750139T
Other languages
English (en)
Other versions
DE3750139T2 (de
Inventor
Dennis L Kasper
Harold J Jennings
Nancy J Levy
Michael R Wessels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of DE3750139D1 publication Critical patent/DE3750139D1/de
Application granted granted Critical
Publication of DE3750139T2 publication Critical patent/DE3750139T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE3750139T 1986-04-16 1987-04-14 Bakterielle antigene, antikörper, impfstoffe und deren herstellung. Expired - Lifetime DE3750139T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85284086A 1986-04-16 1986-04-16
PCT/US1987/000845 WO1987006267A1 (en) 1986-04-16 1987-04-14 Bacterial antigens, antibodies, vaccines, and methods of manufacture

Publications (2)

Publication Number Publication Date
DE3750139D1 true DE3750139D1 (de) 1994-07-28
DE3750139T2 DE3750139T2 (de) 1994-10-06

Family

ID=25314361

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750139T Expired - Lifetime DE3750139T2 (de) 1986-04-16 1987-04-14 Bakterielle antigene, antikörper, impfstoffe und deren herstellung.

Country Status (7)

Country Link
EP (1) EP0302887B1 (de)
JP (2) JP2754000B2 (de)
AT (1) ATE107703T1 (de)
CA (1) CA1305918C (de)
DE (1) DE3750139T2 (de)
DK (1) DK175487B1 (de)
WO (1) WO1987006267A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp A vaccine made from polysaccharide and protein
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
JPH05502157A (ja) * 1989-09-18 1993-04-22 ブリガム アンド ウィメンズ ホスピタル グループｂ連鎖球菌３型莢膜オリゴ糖の酵素学的産生及び回収
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
EP0630260B1 (de) * 1991-03-12 2001-01-24 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Konjugate bestehend aus polysaccharid und protein
FR2682388B1 (fr) * 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
PT667787E (pt) * 1992-09-24 2001-10-31 Brigham & Womens Hospital Vacinas de conjugado de polissacarido-proteina de estreptococos do grupo b do tipo ii e tipo v
AU722078B2 (en) * 1992-11-02 2000-07-20 Brigham And Women's Hospital Conjugate vaccine against group B Streptococcus
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
EP0699689B1 (de) * 1994-08-19 1999-12-01 Societe Des Produits Nestle S.A. Verzweigtes Polysaccharide, es produzierender Mikroorganismus und Zusammensetzungen welche sie enthalten
US5695768A (en) * 1995-06-07 1997-12-09 Alberta Research Council Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
US5866132A (en) * 1995-06-07 1999-02-02 Alberta Research Council Immunogenic oligosaccharide compositions
NZ309713A (en) * 1995-06-07 1999-11-29 Alberta Res Council Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
PT1023435E (pt) * 1997-10-17 2007-01-31 Nestle Sa Nova espécie de bactéria láctica
CA2777837C (en) * 2008-10-27 2017-07-11 Novartis Ag Purification method
CN115572716B (zh) * 2022-09-30 2023-06-16 云南沃森生物技术股份有限公司 抗iii型b群链球菌荚膜多糖单克隆抗体及杂交瘤细胞株

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207414A (en) * 1978-08-16 1980-06-10 President And Fellows Of Harvard College Polysaccharide antigens
US4413057A (en) * 1980-04-14 1983-11-01 Merck & Co., Inc. Group B streptococcal capsular polysaccharides
US4356263A (en) * 1980-06-09 1982-10-26 President And Fellows Of Harvard College Method of making a polysaccharide vaccine

Also Published As

Publication number Publication date
ATE107703T1 (de) 1994-07-15
JPH08277298A (ja) 1996-10-22
DK656687A (da) 1987-12-15
CA1305918C (en) 1992-08-04
EP0302887A4 (de) 1989-11-20
DK175487B1 (da) 2004-11-08
EP0302887B1 (de) 1994-06-22
JPH01500561A (ja) 1989-03-01
DK656687D0 (da) 1987-12-15
JP2754000B2 (ja) 1998-05-20
DE3750139T2 (de) 1994-10-06
WO1987006267A1 (en) 1987-10-22
EP0302887A1 (de) 1989-02-15

Similar Documents

Publication Publication Date Title
ATE107703T1 (de) Bakterielle antigene, antikörper, impfstoffe und deren herstellung.
NO308413B1 (no) Antigen blanding, DNA-segment som koder for et antigen, rekombinant vektor og vertscelle som innbefatter DNA-segmentet samt anvendelser av et antigen
FI883876A (fi) Menetelmä rokotteen valmistamiseksi streptokokki-infektioita vastaan
NZ223009A (en) Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
NO975434L (no) Fremgangsmåte for fremstilling av influensa hemagglutinin multivalente vaksiner
ATE267258T1 (de) Impfstoffe für das respiratorische-synzytial- virus mit nuklein säuren
FI101632B1 (fi) Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä
ATE7761T1 (de) Impfstoff und herstellungsverfahren.
ATE7855T1 (de) Herstellung von virusantigenen.
DE3175677D1 (en) Polysaccharide antigen from streptococcus and vaccines
FR2599626B1 (fr) Antigene du flavivirus, procede pour sa production et vaccin le contenant
FI950378A (fi) Immuunitesti kollageenin tai kollageenifragmenttien havaitsemiseksi
FI924457A0 (fi) Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
DE68915046D1 (de) Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff.
DE69030099D1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
CA1263307C (en) PSEUDOMONAS NATIVE FLAGELLAR NATIVE FLAGELLAR ANTIGENS AND METHOD OF PRODUCING
FR2517967B1 (de)
Nutter Antigens of Pasteurella tularensis: preparative procedures
Lutz Proctor et al. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population
FR2655853B1 (fr) Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes.
Padyukov et al. Detection of noncapsular pneumococcal antigens.
Pei et al. Identification and characterization of major common antigens from Campylobacter jejuni
KR890010189A (ko) 마우스 하이브리도마 lym-2 및 이로부터 제조한 진단항체
RU99103391A (ru) Способ получения гипериммунной сыворотки против рожи свиней

Legal Events

Date Code Title Description
8364 No opposition during term of opposition